SLC2A1 and Alzheimer disease: Although decreased cerebrovascular protein levels in AD have been reported for LRP-1, P-gp, and GLUT-1 previously [67, 73, 77], we posit that the apparent discordance of our results reflects the heterogeneity of AD subject populations.